YouTube - Video: RSS in Plain English: "Video: RSS in Plain English"
check this out- way of presentation!!!!! excelent. also down to the point. !!!!
streda 30. júna 2010
Role of Aldosterone and Angiotensin II in Insulin Resistance: Abstract and Introduction
Role of Aldosterone and Angiotensin II in Insulin Resistance: Abstract and Introduction: "Role of Aldosterone and Angiotensin II in Insulin Resistance: An Update"
Hyperglycemic Crises in Adult Patients With Diabetes: Introduction
Hyperglycemic Crises in Adult Patients With Diabetes: Introduction: "Hyperglycemic Crises in Adult Patients With Diabetes"
Review of Dr. RA DeFronzo's work
Review of Dr. RA DeFronzo's work: "Dr. RA Defronzo
Status: Laboratory Head"
Status: Laboratory Head"
utorok 29. júna 2010
InCirculation.net - NSAID induced coronary risk, genetics
InCirculation.net - cardiovascular medicine resources, cardiology information, news, guidelines: "Gene variants may influence NSAID-induced coronary risk
18 June 2010
MedWire News: Variants in the prostaglandin-endoperoxide synthase-1 (PTGS1) and C-reactive protein (CRP) genes may influence the risk for acute coronary events associated with non-steroidal antiinflammatory drugs (NSAID), Canadian researchers believe.
However, they admit that their findings, which appear in the American Journal of Cardiology, are preliminary and require confirmation in larger cohorts."
18 June 2010
MedWire News: Variants in the prostaglandin-endoperoxide synthase-1 (PTGS1) and C-reactive protein (CRP) genes may influence the risk for acute coronary events associated with non-steroidal antiinflammatory drugs (NSAID), Canadian researchers believe.
However, they admit that their findings, which appear in the American Journal of Cardiology, are preliminary and require confirmation in larger cohorts."
utorok 15. júna 2010
XXXXXXXXXXClinical Research & Clinical Trials
Clinical Research & Clinical Trials: "What is clinical research?"
Clinical Research Regulatory Information
Clinical Research Regulatory Information: "Clinical Research Regulatory Information"
XXXXXX Steps involved in clinical research efforts
Steps involved in clinical research efforts: "Steps involved in clinical research efforts"
BioMed Central | Clinical Trials
BioMed Central Clinical Trials: "Clinical trials and BioMed Central"
CEBM > Centre for Evidence-Based Medicine in Oxford in
CEBM > Home: "Welcome to the web site of the Centre for Evidence-Based Medicine in Oxford in the UK."
Publishing study protocols: making them visible will improve registration, reporting and recruitment
BioMed Central Full text Publishing study protocols: making them visible will improve registration, reporting and recruitment: "Publishing study protocols: making them visible will improve registration, reporting and recruitment"
The CONSORT Group > CONSORT Statement > Overview
The CONSORT Group > CONSORT Statement > Overview: "The CONSORT Statement is intended to improve the reporting of a randomized controlled trial (RCT), enabling readers to understand a trial's design, conduct, analysis and interpretation, and to assess the validity of its results. It emphasizes that this can only be achieved through complete transparency from authors."
Emerging Themes in Epidemiology | Full text | Testing bias in clinical databases: methodological considerations
Emerging Themes in Epidemiology Full text Testing bias in clinical databases: methodological considerations: "Testing bias in clinical databases: methodological considerations"
The new CONSORT statement -- Antes 340: c1432 -- BMJ
The new CONSORT statement -- Antes 340: c1432 -- BMJ: "The new CONSORT statement
The guidance is clear, but awareness and endorsement are lagging behind"
The guidance is clear, but awareness and endorsement are lagging behind"
BioMed Central || When Failure Should Be the Option
BioMed Central Full text When Failure Should Be the Option: "When failure should be the option"
about possible yield from failed phase II studies
- drugs found ineffective, but safe
? maybe more effective for other target, other disease """"!!!!!
about possible yield from failed phase II studies
- drugs found ineffective, but safe
? maybe more effective for other target, other disease """"!!!!!
DECLARATION OF HELSINKI
Office of Human Subjects Research: "WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI
Ethical Principles for Medical Research Involving Human Subjects
Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the
29th WMA General Assembly, Tokyo, Japan, October 1975
35th WMA General Assembly, Venice, Italy, October 1983
41st WMA General Assembly, Hong Kong, September 1989
48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996
and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000
Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002 Note of Clarification on Paragraph 30 added by the WMA General Assembly, Tokyo 2004"
Ethical Principles for Medical Research Involving Human Subjects
Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the
29th WMA General Assembly, Tokyo, Japan, October 1975
35th WMA General Assembly, Venice, Italy, October 1983
41st WMA General Assembly, Hong Kong, September 1989
48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996
and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000
Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002 Note of Clarification on Paragraph 30 added by the WMA General Assembly, Tokyo 2004"
FDA: Guidances, Information Sheets, and Notices
Guidances, Information Sheets, and Notices: "Guidances, Information Sheets, and Notices"
Understanding Clinical Trials - ClinicalTrials.gov
Understanding Clinical Trials - ClinicalTrials.gov: "Understanding Clinical Trials"
http://clinicaltrials.ifpma.org/clinicaltrials/index.php?id=134&L=0&w=diabetes&s=true&isHomeLink=true
Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity
http://clinicaltrials.ifpma.org/clinicaltrials/index.php?id=134&L=0&w=diabetes&s=true&isHomeLink=true
Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity
NEJM -- Disclosure of Financial Relationships to Participants in Clinical Research
NEJM -- Disclosure of Financial Relationships to Participants in Clinical Research: "Disclosure of Financial Relationships to Participants in Clinical Research"
Translational Medicine: A two-way road
Journal of Translational Medicine Full text Translational Medicine: A two-way road: "Translational Medicine: A two-way road"
pondelok 14. júna 2010
nedeľa 13. júna 2010
OpenClinical.org
clinical knowledge management for healthcare
OPENCLINICAL.ORG
relevant books, white papers, regulations ...
OPENCLINICAL.ORG
relevant books, white papers, regulations ...
piatok 11. júna 2010
Psychological Tests and Test Interpretation Tools
Psychological Tests and Test Interpretation Tools: "I have created a suite of over 25 repeatable tests. For now, none of them have been normed but they can be used for cognitive rehabilitation and qualitative assessment. The suite includes tests of attention, long-term and working memory, reasoning, reaction time, executive functions and visual-spatial processing.
This is available upon request.
SPSS Syntax"
This is available upon request.
SPSS Syntax"
Enzmann_Software
Enzmann_Software: "Dirk Enzmann - Statistical Software (Some Useful Things)
Below you find some small executables, SPSS macros, EXCEL-templates, R functions (see: http://www.r-project.org/) and Stata ado-files I wrote for special calculations in statistical analyses. The executable programs are written in Pascal 7.0 and run under Windows (3.x, 9x, NT4, XP). The files can be downloaded and spread without further permisson under the condition that they remain unchanged. They have been tested as virus free. The author is not liable to any damages caused by their use. Comments on improvements are welcome"
Below you find some small executables, SPSS macros, EXCEL-templates, R functions (see: http://www.r-project.org/) and Stata ado-files I wrote for special calculations in statistical analyses. The executable programs are written in Pascal 7.0 and run under Windows (3.x, 9x, NT4, XP). The files can be downloaded and spread without further permisson under the condition that they remain unchanged. They have been tested as virus free. The author is not liable to any damages caused by their use. Comments on improvements are welcome"
Interaction between two continuous variables - PsychWiki - A Collaborative Psychology Wiki
Interaction between two continuous variables - PsychWiki - A Collaborative Psychology Wiki: "Interaction between two continuous variables
From PsychWiki - A Collaborative Psychology Wiki
Jump to: navigation, search
Statistical programs, like SPSS, do not always have 'point-and-click' commands for every possible statistical test. This page is a description of how to test the interaction between two continuous variables. Two approaches are described below:
(1) three steps to conduct the interaction using commands within SPSS, and
(2) Interaction! software by Daniel S. Soper that performs statistical analysis and graphics for interactions between dichotomous, categorical, and continuous variables."
From PsychWiki - A Collaborative Psychology Wiki
Jump to: navigation, search
Statistical programs, like SPSS, do not always have 'point-and-click' commands for every possible statistical test. This page is a description of how to test the interaction between two continuous variables. Two approaches are described below:
(1) three steps to conduct the interaction using commands within SPSS, and
(2) Interaction! software by Daniel S. Soper that performs statistical analysis and graphics for interactions between dichotomous, categorical, and continuous variables."
citation, refererence management, online
check out.
biomedexperts
http://www.biomedexperts.com/Profile.bme/497839/Per-Henrik_Groop
citeuLike (SPRINGER)
connotea
delicious
SCOPUS
biomedexperts
http://www.biomedexperts.com/Profile.bme/497839/Per-Henrik_Groop
citeuLike (SPRINGER)
connotea
delicious
SCOPUS
štvrtok 10. júna 2010
OCT identifies additional vulnerable lesions in post-AMI patients
OCT identifies additional vulnerable lesions in post-AMI patients: "OCT finds additional at-risk lesions in AMI patients
January 29, 2010 Shelley Wood
Wakayama, Japan - In one of the first studies to use optical coherence tomography (OCT) imaging to compare plaque vulnerability in different groups of at-risk subjects, Dr Takashi Kubo (Wakayama Medical University, Japan) and colleagues say they can identify important differences in the plaques of AMI patients and of patients with stable angina [1]. Investigators also found that plaques that met the definition of thin-cap fibroatheroma (TCFA), as well as thinner fibrous caps generally, were more common in the AMI patients than in the stable-angina subjects and that this was true not just of the infarct-related lesions, but also of the noninfarct lesions."
January 29, 2010 Shelley Wood
Wakayama, Japan - In one of the first studies to use optical coherence tomography (OCT) imaging to compare plaque vulnerability in different groups of at-risk subjects, Dr Takashi Kubo (Wakayama Medical University, Japan) and colleagues say they can identify important differences in the plaques of AMI patients and of patients with stable angina [1]. Investigators also found that plaques that met the definition of thin-cap fibroatheroma (TCFA), as well as thinner fibrous caps generally, were more common in the AMI patients than in the stable-angina subjects and that this was true not just of the infarct-related lesions, but also of the noninfarct lesions."
Diagnostic yield of angiography
Diagnostic yield of angiography: "ongoing National Institutes of Health-sponsored Prospective Imaging Study for Evaluation of Chest Pain (PROMISE), comparing CT angiography with functional stress testing in 10 000 patients, will provide important insights into how CT can be used to better risk-stratify this population."
NEJM PATEL 2010 xxxxxx
NEJM PATEL 2010 xxxxxx
Eprotirome with statin therapy
Eprotirome with statin therapy: "Eprotirome further reduces cholesterol levels in statin-treated patients
March 10, 2010
Download slides
Baltimore, MD - Adding the investigational thyroid hormone analog eprotirome (Karo Bio) to statin therapy in patients with dyslipidemia results in substantially further reductions in LDL cholesterol and other lipid and lipoprotein levels, a new study shows [1]. The improvements in the atherogenic profile occurred without adversely affecting the heart or skeletal system, two common side effects of thyroid hormone analogs, report investigators."
March 10, 2010
Download slides
Baltimore, MD - Adding the investigational thyroid hormone analog eprotirome (Karo Bio) to statin therapy in patients with dyslipidemia results in substantially further reductions in LDL cholesterol and other lipid and lipoprotein levels, a new study shows [1]. The improvements in the atherogenic profile occurred without adversely affecting the heart or skeletal system, two common side effects of thyroid hormone analogs, report investigators."
streda 9. júna 2010
Weight, blood pressure, and dietary benefits after... [J Med Internet Res. 2008] - PubMed result
Weight, blood pressure, and dietary benefits after... [J Med Internet Res. 2008] - PubMed result: "Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study."
RIZIKOVÝ PROFIL A OČAKÁVANÝ PRÍNOS FARMAKOLOGICKEJ LIEČBY U NOVODIAGNOSTIKOVANÝCH DIABETIKOV 2. TYPU
SAMEDI: "Interná medicína 2005 / 9
RIZIKOVÝ PROFIL A OČAKÁVANÝ PRÍNOS FARMAKOLOGICKEJ LIEČBY U NOVODIAGNOSTIKOVANÝCH DIABETIKOV 2. TYPU
Ivan Tkáč, Lucia Baldaufová"
Interná medicína 2005 / 9
RIZIKOVÝ PROFIL A OČAKÁVANÝ PRÍNOS FARMAKOLOGICKEJ LIEČBY U NOVODIAGNOSTIKOVANÝCH DIABETIKOV 2. TYPU
Ivan Tkáč, Lucia Baldaufová
Pacienti s diabetes mellitus 2. typu majú zvýšené riziko rozvoja kardiovaskulárnych ochorení už v čase stanovenia diagnózy diabetu. V súbore 1471 novodiagnostikovaných diabetikov 2. typu sme analyzovali spektrum rizikových faktorov aterosklerózy. Priemerné hodnoty glykovaného hemoglobínu (GHb) pri stanovení diagnózy diabetu boli 8,4 %, priemerné hladiny LDL cholesterolu boli 3,4 mmol/l a priemerné hodnoty krvného tlaku boli 140/84 mmHg. V čase stanovenia diagnózy cukrovky malo 74 % diabetikov hladinu GHb >7,5 %, 87 % diabetikov malo hladinu LDL cholesterolu > 2,5 mmol/l a 64 % diabetikov malo hodnoty systolického tlaku krvi (STK) > 130 mmHg. Za použitia kalkulátora rizika UKPDS Risk Engine bolo vypočítané absolútne 10-ročné riziko rozvoja ICHS u mužov s novozisteným diabetom 23,1 %, zatiaľ čo u žien bolo toto riziko 14,4 %. Ak by boli u pacientov dosiahnuté cieľové hladiny GHb, LDL cholesterolu a STK, potom by sa vypočítané riziko rozvoja ICHS u oboch pohlaví znížilo o vyše 40 % a riziko kardiovaskulárnej mortality by sa znížilo až na polovicu. Uvedené fakty svedčia a vysokej rizikovosti pacientov s novodiagnostikovaným diabetom 2. typu a o vysokom preventívnom potenciáli intervencií zameraných na liečbu hyperglykémie, hypercholesterolémie a hypertenzie. Kľúčové slová: diabetes mellitus 2. typu, rizikové faktory aterosklerózy, dyslipidémia, hypertenzia
RISK PROFILE AND ANTICIPATED BENEFIT OF PHARMACOLOGICAL TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES
The patients with type 2 diabetes have an increased risk of cardiovascular disease even in the time when the diagnosis of diabetes is established. We have analysed atherosclerosis risk factor profile in a group of 1471 newly diagnosed patients with type 2 diabetes. Mean glycated haemoglobin (GHb) at the time of diagnosis was 8,4 %, mean LDL cholesterol level was 3,4 mmol/l, and mean blood pressure was 140/84 mmHg. At the time of diagnosis of diabetes 74 % of diabetic patients had GHb level >7,5 %, 87 % of patients had LDL cholesterol level > 2,5 mmol/l, and 64 % of diabetic patients had systolic blood pressure above 130 mmHg. Using the UKPDS Risk Engine calculated 10-year absolute risk of coronary heart disease in men with newly diagnosed type 2 diabetes is 23,1 %, while in women it is 14,4 %. If target GHb, LDL cholesterol and systolic blood pressure values were achieved, then calculated risk of coronary disease in both genders would decrease by more than 40 % and the risk of fatal cardiovascular disease would be reduced by one half. These facts indicate high risk of patients with newly diagnosed type 2 diabetes and show also high preventive potential of treatments focused on high blood glucose, cholesterol and blood pressure levels. Key words: type 2 diabetes mellitus, atherosclerosis risk factors, dyslipidaemia, hypertension
Interná med. 2005; 5 (9): 473-477
RIZIKOVÝ PROFIL A OČAKÁVANÝ PRÍNOS FARMAKOLOGICKEJ LIEČBY U NOVODIAGNOSTIKOVANÝCH DIABETIKOV 2. TYPU
Ivan Tkáč, Lucia Baldaufová"
Interná medicína 2005 / 9
RIZIKOVÝ PROFIL A OČAKÁVANÝ PRÍNOS FARMAKOLOGICKEJ LIEČBY U NOVODIAGNOSTIKOVANÝCH DIABETIKOV 2. TYPU
Ivan Tkáč, Lucia Baldaufová
Pacienti s diabetes mellitus 2. typu majú zvýšené riziko rozvoja kardiovaskulárnych ochorení už v čase stanovenia diagnózy diabetu. V súbore 1471 novodiagnostikovaných diabetikov 2. typu sme analyzovali spektrum rizikových faktorov aterosklerózy. Priemerné hodnoty glykovaného hemoglobínu (GHb) pri stanovení diagnózy diabetu boli 8,4 %, priemerné hladiny LDL cholesterolu boli 3,4 mmol/l a priemerné hodnoty krvného tlaku boli 140/84 mmHg. V čase stanovenia diagnózy cukrovky malo 74 % diabetikov hladinu GHb >7,5 %, 87 % diabetikov malo hladinu LDL cholesterolu > 2,5 mmol/l a 64 % diabetikov malo hodnoty systolického tlaku krvi (STK) > 130 mmHg. Za použitia kalkulátora rizika UKPDS Risk Engine bolo vypočítané absolútne 10-ročné riziko rozvoja ICHS u mužov s novozisteným diabetom 23,1 %, zatiaľ čo u žien bolo toto riziko 14,4 %. Ak by boli u pacientov dosiahnuté cieľové hladiny GHb, LDL cholesterolu a STK, potom by sa vypočítané riziko rozvoja ICHS u oboch pohlaví znížilo o vyše 40 % a riziko kardiovaskulárnej mortality by sa znížilo až na polovicu. Uvedené fakty svedčia a vysokej rizikovosti pacientov s novodiagnostikovaným diabetom 2. typu a o vysokom preventívnom potenciáli intervencií zameraných na liečbu hyperglykémie, hypercholesterolémie a hypertenzie. Kľúčové slová: diabetes mellitus 2. typu, rizikové faktory aterosklerózy, dyslipidémia, hypertenzia
RISK PROFILE AND ANTICIPATED BENEFIT OF PHARMACOLOGICAL TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES
The patients with type 2 diabetes have an increased risk of cardiovascular disease even in the time when the diagnosis of diabetes is established. We have analysed atherosclerosis risk factor profile in a group of 1471 newly diagnosed patients with type 2 diabetes. Mean glycated haemoglobin (GHb) at the time of diagnosis was 8,4 %, mean LDL cholesterol level was 3,4 mmol/l, and mean blood pressure was 140/84 mmHg. At the time of diagnosis of diabetes 74 % of diabetic patients had GHb level >7,5 %, 87 % of patients had LDL cholesterol level > 2,5 mmol/l, and 64 % of diabetic patients had systolic blood pressure above 130 mmHg. Using the UKPDS Risk Engine calculated 10-year absolute risk of coronary heart disease in men with newly diagnosed type 2 diabetes is 23,1 %, while in women it is 14,4 %. If target GHb, LDL cholesterol and systolic blood pressure values were achieved, then calculated risk of coronary disease in both genders would decrease by more than 40 % and the risk of fatal cardiovascular disease would be reduced by one half. These facts indicate high risk of patients with newly diagnosed type 2 diabetes and show also high preventive potential of treatments focused on high blood glucose, cholesterol and blood pressure levels. Key words: type 2 diabetes mellitus, atherosclerosis risk factors, dyslipidaemia, hypertension
Interná med. 2005; 5 (9): 473-477
pondelok 7. júna 2010
prednášky - bioštatistika, úvod do vedecko výskumnej činnosti
EXCELENT resource for PhD students (SLOVAK)
BY KISH, lead by Dr Andrea Madarasová Gecková, including insightful lectures by Dr. Jaro Rosenberger
BY KISH, lead by Dr Andrea Madarasová Gecková, including insightful lectures by Dr. Jaro Rosenberger
*X* Multiple Regression with Categorical Predictor Variables - Text
Multiple Regression with Categorical Predictor Variables - Text: "ANOVA is a special case of linear regression when the variables have been dummy coded."
excelent example, worked example in SPSS
excelent example, worked example in SPSS
regression vs ANOVA, qualitative, independent variables, dummy variables
regression vs ANOVA
QUALITATIVE Independent variables vs DUMMY VARIABLES PDF.
12 PAGES , syntax, examples from SPSS
QUALITATIVE Independent variables vs DUMMY VARIABLES PDF.
12 PAGES , syntax, examples from SPSS
Multivariate Statistics - Categorical Variables
Multivariate Statistics - Categorical Variables: "Part VII: Multiple Regression (MR)
Using Categorical Variables in MR"
Using Categorical Variables in MR"
*x* Examples: Linear Models with Dummy Variables, R
Statistics 5102 (Geyer, Spring 2010) Examples: Linear Models with Dummy Variables: "Categorical Predictors and Dummy Variables
The subject of this web page is linear models in which some or all of the predictors are categorical. Special cases are called ANOVA and ANCOVA.
In principle, there is no problem. The model matrix is allowed to be any function whatsoever of the predictor variables (covariates).
In practice, we need to explain the most commonly used way in which the model matrix is made to depend on categorical covariates."
The subject of this web page is linear models in which some or all of the predictors are categorical. Special cases are called ANOVA and ANCOVA.
In principle, there is no problem. The model matrix is allowed to be any function whatsoever of the predictor variables (covariates).
In practice, we need to explain the most commonly used way in which the model matrix is made to depend on categorical covariates."
How large of SE is too large?
Epidemiology and Beyond: How large of SE is too large?: "Rules of Thumb: How large of SE is too large?"
SE = STANDARD ERROR
SE = STANDARD ERROR
Epidemiology and Beyond Public Accessible Research Data
Epidemiology and Beyond: "Public Accessible Research Data"
Epidemiology and Beyond: stats freeware
Epidemiology and Beyond: "My Favorite Statistic and Math Freeware"
Open Atrium vs BaseCamp project management
Manage Your Projects With Open Atrium Idealware: "Manage Your Projects With Open Atrium
By Steve Backman, August 2009
I’m trying out Open Atrium. http://openatrium.com/ Now in first beta, Open Atrium from Development Seed consolidates powerful project management features to Drupal in a modern, polished format.
When we first started bearing down on Drupal two years ago, about the first thing we wanted to do manage independent projects on our own www.dbdes.com site. We got reasonably far, with the ability to define clients, projects, tasks and organize blog-like discussion and documents for each. Given the state of the art two years ago in Drupal and our own priorities, we eventually shelved it in favor of a generally positive relationship with Basecamp (http://www.basecamphq.com). Meanwhile, many of our Drupal sites required one or another set of Intranet features, and each one got delivered in customized, one-off ways."
By Steve Backman, August 2009
I’m trying out Open Atrium. http://openatrium.com/ Now in first beta, Open Atrium from Development Seed consolidates powerful project management features to Drupal in a modern, polished format.
When we first started bearing down on Drupal two years ago, about the first thing we wanted to do manage independent projects on our own www.dbdes.com site. We got reasonably far, with the ability to define clients, projects, tasks and organize blog-like discussion and documents for each. Given the state of the art two years ago in Drupal and our own priorities, we eventually shelved it in favor of a generally positive relationship with Basecamp (http://www.basecamphq.com). Meanwhile, many of our Drupal sites required one or another set of Intranet features, and each one got delivered in customized, one-off ways."
Medrio: EDC Overnight cf Open clinica
Medrio: EDC Overnight: "Medrio provides electronic data capture (EDC) software with unique capabilities: study managers configure Medrio directly without reliance on software programmers. The result is a vast improvement in:
Speed: study online in as little as 1 day
Cost: low monthly subscription per study
Simplicity: automated reports and statistics
Medrio supports phase I-IV trials, outcomes research, registries, retrospective chart reviews, and other clinical and animal health studies where these advantages are most important, all within a secure regulatory compliant environment."
Speed: study online in as little as 1 day
Cost: low monthly subscription per study
Simplicity: automated reports and statistics
Medrio supports phase I-IV trials, outcomes research, registries, retrospective chart reviews, and other clinical and animal health studies where these advantages are most important, all within a secure regulatory compliant environment."
open atrium calendar, features
"Open Atrium allows you to share events and meetings with your team, using the calendar feature. To enable the calendar in your group you have to add the calendar as a feature."
pdf - opena atrium features
pdf - opena atrium features
TrustTheEvidence.net - what we are about | TrustTheEvidence.net
TrustTheEvidence.net - what we are about TrustTheEvidence.net: "Trusttheevidence.net was formed by two friends who first met at Medical School in Oxford. During PhDs at the OXVASC research programme, they revisited their shared interest in health research and its impact on clinical care. The ideas for this blog were first mooted over a few pints of ale in the public houses of the golden triangle (see Google map below). Research that matters should be transmitted to and understood by a wider audience. We feel this is a neglected area."
CEBM > Training & Education > CEBM Workshop Videos > Dr Carl Heneghan #2
CEBM > Training & Education > CEBM Workshop Videos > Dr Carl Heneghan #2: "Dr Carl Heneghan - Diagnostic Tests #2"
nedeľa 6. júna 2010
JavaScript Kit- Content Management scripts
JavaScript Kit- Content Management scripts: "A 'plug and play' script that makes your regular HTML tables sortable! Click on the table headers, and the column that follows is sorted either in descending or ascending order. Easy to install, and functions in IE5+ and NS6+."
sobota 5. júna 2010
EuroRec: - ARGOS
EuroRec: European Institute for Health Records - ARGOS: "The overall goal of the ARGOS eHealth Pilot Project is to contribute to establishing a “Transatlantic Observatory for Meeting Global Health Policy Challenges through ICT-Enabled Solutions” in order to develop and promote “Common Methods for Responding to Global eHealth Challenges in the EU and the US”. EU and US care about the global challenges because (a) citizens travel and migrate globally and there is a wish to foster good healthcare everywhere (b) the EU and US wish to refine their products to better penetrate global markets (c) experiences and lessons learned globally are useful in Europe and the US."
EuroRec: European Institute for Health Records - News
EuroRec: European Institute for Health Records - News: "The ICT 2010 conference will take place in Brussels on 27-29 September 2010. ICT 2010 is organised by the European Commission and hosted by the Belgian Presidency of the European Union. Around 4.500 participants are expected to attend this event."
EuroRec: European Institute for Health Records - News
EuroRec: European Institute for Health Records - News: "Presentations High Level eHealth Ministerial Conference & WoHIT"
EuroRec: European Institute for Health Records - services
EuroRec: European Institute for Health Records - services: "EHR Archetypes
Background
EHR Archetypes are a formal, rigorous and standardised (interoperable) specification for an agreed consensus or best practice representation of a clinical data structure within an electronic health record.
The strength of the approach taken internationally on the communication (sharing) or electronic health record information has been the development of a rigorous generic representation suitable for all kinds of entries. Provided that the communications architecture is common to both a sending and a receiving information system, any health record extract will contain all of the structure and names required for it to be interpreted faithfully on receipt even if its organisation and the nature of the clinical content have not been 'agreed' in advance."
Background
EHR Archetypes are a formal, rigorous and standardised (interoperable) specification for an agreed consensus or best practice representation of a clinical data structure within an electronic health record.
The strength of the approach taken internationally on the communication (sharing) or electronic health record information has been the development of a rigorous generic representation suitable for all kinds of entries. Provided that the communications architecture is common to both a sending and a receiving information system, any health record extract will contain all of the structure and names required for it to be interpreted faithfully on receipt even if its organisation and the nature of the clinical content have not been 'agreed' in advance."
EuroRec: European Institute for Health Records
EuroRec: European Institute for Health Records: "The EUROREC Institute (EuroRec) is an independent not-for-profit organisation, promoting in Europe the use of high quality Electronic Health Record systems (EHRs). One of its main missions is to support, as the European authorised certification body, EHRs certification development, testing and assessment by defining functional and other criteria."
CF AJ slovak verzia
CF AJ slovak verzia
openEHR :: future proof and flexible EHR specifications
Welcome to openEHR - openEHR :: future proof and flexible EHR specifications: "Welcome to openEHR
openEHR is about enabling ICT to effectively support healthcare, medical research and related areas. Today ICT is used ubiquitously elsewhere, but is far from effective in Healthcare. The main problem in health is the lack of shareable and computable information."
openEHR is about enabling ICT to effectively support healthcare, medical research and related areas. Today ICT is used ubiquitously elsewhere, but is far from effective in Healthcare. The main problem in health is the lack of shareable and computable information."
SNOMED CT_IHTSDO: Slovak Republic
IHTSDO: Slovak Republic: "The Slovak Republic's representative to the International Health Terminology Standards Development Organisation (IHT SDO®) is the National Health Information Center (NHIC). NHIC is the state contributory organization established by the Ministry of Health of Slovak Republic. NHIC became the full member of IHT SDO in November 2009 thus joining the international effort to develop, maintain and use SNOMED CT in the healthcare systems."
TRANSLATION - Experience by DANISH, SWEDISH, CANADIANS
TRANSLATION - Experience by DANISH, SWEDISH, CANADIANS
IGF2BP2 variations influence repaglinide response ... [Acta Pharmacol Sin. 2010] - PubMed result
IGF2BP2 variations influence repaglinide response ... [Acta Pharmacol Sin. 2010] - PubMed result: "IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population."
Open Workbench - Home
Open Workbench - Home: "Open Workbench is an open source desktop application that provides robust project scheduling and management functionality. Already the scheduling standard for more than 100,000 project managers worldwide, Open Workbench is a free and powerful alternative to Microsoft Project."
Clinical Trial Software | OpenClinica
Clinical Trial Software OpenClinica: "Professional Open Source for Clinical Research.
OpenClinica is clinical trials software for electronic data capture (EDC) and clinical data management (CDM). This website contains official resources and information about OpenClinica."
OpenClinica is clinical trials software for electronic data capture (EDC) and clinical data management (CDM). This website contains official resources and information about OpenClinica."
Clinical Trial Software | OpenClinica - OpenClinica Tutorial Videos
Clinical Trial Software OpenClinica - OpenClinica Tutorial Videos: "OpenClinica Tutorial Videos
The following video tutorials demonstrate installing and using OpenClinica."
The following video tutorials demonstrate installing and using OpenClinica."
The OpenClinica Blog
The OpenClinica Blog: "Musings on open source and open standards in clinical trial software and healthcare IT"
Taskjuggler - The Open Source Project Management Software - Home
Taskjuggler - The Open Source Project Management Software - Home: "TaskJuggler is a modern and powerful, Free and Open Source Software project management tool. Its new approach to project planing and tracking is more flexible and superior to the commonly used Gantt chart editing tools. It has already been successfully used in many projects and scales easily to projects with hundreds of resources and thousands of tasks."
Eureka | Download Eureka software for free at SourceForge.net
Eureka Download Eureka software for free at SourceForge.net: "An application useful to manage work shifts. Windows standalone executable for operators and web interface for workers. Multi-area, multi-schema, multi-language architecture. Layer for RDBMS technology independence, DB and LDAP authentication supported."
List of open source healthcare software - Wikipedia, the free encyclopedia
List of open source healthcare software - Wikipedia, the free encyclopedia: "List of open source healthcare software"
SPSS Data Definition Syntax
SPSS Data Definition Syntax: "Statistical Package for the Social Sciences
Syntax for Data Definition Commands"
older blog - refers to SPSS v 10, but nice layout, basic concepts useful
Syntax for Data Definition Commands"
older blog - refers to SPSS v 10, but nice layout, basic concepts useful
piatok 4. júna 2010
Stats: Adjusting for a baseline measurement (February 28, 2005)
Stats: Adjusting for a baseline measurement (February 28, 2005): "Adjusting for a baseline measurement (February 28, 2005)."
Arterial Stiffness in the Young: Assessment, Determinants, and Implications. - novoseek
Arterial Stiffness in the Young: Assessment, Determinants, and Implications. - novoseek: "Arterial Stiffness in the Young: Assessment, Determinants, and Implications.
KCJ 2010,Apr,01;40(4):153-162; (PMCID: 2859331, DOI:10.4070/kcj.2010.40.4.153)"
KCJ 2010,Apr,01;40(4):153-162; (PMCID: 2859331, DOI:10.4070/kcj.2010.40.4.153)"
Novoseek XXXXXX
Your new biomedical search engine – Novoseek: "What is novoseek?
Biomedical search engine for medical journals in Pubmed, Free Full Text and U.S. Grants that helps to:
Retrieve meaningful documents related to your search.
Narrow your search to find results in the relevant scientific journals.
Identify the most relevant biomedical concepts to your search."
Biomedical search engine for medical journals in Pubmed, Free Full Text and U.S. Grants that helps to:
Retrieve meaningful documents related to your search.
Narrow your search to find results in the relevant scientific journals.
Identify the most relevant biomedical concepts to your search."
iGoogle for Productivity and Outreach
iGoogle for Productivity and Outreach: "iGoogle for Productivity and Outreach"
Interpreting results: Repeated measures two-way ANOVA
Interpreting results: Repeated measures two-way ANOVA: "Are you sure that ANOVA is the best analysis?
Before interpreting the ANOVA results, first do a reality check. If one of the factors is a quantitative factor like time or dose, consider alternatives to ANOVA.
Interpreting P values from repeated measures two-way ANOVA"
Before interpreting the ANOVA results, first do a reality check. If one of the factors is a quantitative factor like time or dose, consider alternatives to ANOVA.
Interpreting P values from repeated measures two-way ANOVA"
Interpreting results: Two-way ANOVA
Interpreting results: Two-way ANOVA: "Interpreting results: Two-way ANOVA"
New View of Statistics: Repeated Measures - 5
New View of Statistics: Repeated Measures - 5: "Other Repeated-Measures Models"
New View of Statistics: Repeated Measures - 3
New View of Statistics: Repeated Measures - 3: "Repeated-Measures ANOVA with three or more trials and no between-subjects effect"
Stats: Adjusting for a baseline measurement (February 28, 2005)
Stats: Adjusting for a baseline measurement (February 28, 2005): "Adjusting for a baseline measurement (February 28, 2005).
Someone asked me today about how to analyze a two group experiment with a baseline value. This is common research design. Researchers will assess all patients at the beginning of the study. They then randomly assign half of these patients to receive an intervention and half to be in a control group. Then they take a second measurement of the same outcome. The measurement at the beginning of the study, the baseline value, helps improve the research design by removing some of the variation in the data."
Someone asked me today about how to analyze a two group experiment with a baseline value. This is common research design. Researchers will assess all patients at the beginning of the study. They then randomly assign half of these patients to receive an intervention and half to be in a control group. Then they take a second measurement of the same outcome. The measurement at the beginning of the study, the baseline value, helps improve the research design by removing some of the variation in the data."
PubMed Online Training
PubMed Online Training: "The following are brief animated tutorials with audio for using PubMed. Running times are rounded to the nearest minute. Click on the link to launch the tour."
štvrtok 3. júna 2010
Brain Map
Brain Map: "Welcome to the Brain Map website.
Our site is aimed at providing you with information about magneto-encephalo-graphy, also know as MEG.
MEG is a non invasive and accurate imaging technique for localizing brain activity.
On this website you will find valuable information on MEG imaging and who it's meant for.
Bar Ilan is honored to offer the only MEG clinic services in the Mediterranean area.
FIND OUT MORE ABOUT MEG"
Our site is aimed at providing you with information about magneto-encephalo-graphy, also know as MEG.
MEG is a non invasive and accurate imaging technique for localizing brain activity.
On this website you will find valuable information on MEG imaging and who it's meant for.
Bar Ilan is honored to offer the only MEG clinic services in the Mediterranean area.
FIND OUT MORE ABOUT MEG"
Cited by ..
Cited by ..: "Estimates of heritable and environmental components of familial breast cancer using family history information
E Couto and K Hemminki
Br J Cancer. 2007 June 4; 96(11): 1740–1742. Published online 2007 May 1. doi: 10.1038/sj.bjc.6603753.
PMCID: PMC2359918"
E Couto and K Hemminki
Br J Cancer. 2007 June 4; 96(11): 1740–1742. Published online 2007 May 1. doi: 10.1038/sj.bjc.6603753.
PMCID: PMC2359918"
Cited by ..
Cited by ..: "Using Risk-based Sampling to Enrich Cohorts for Endpoints, Genes, and Exposures
Clarice R. Weinberg, David L. Shore, David M. Umbach, and Dale P. Sandler
Am J Epidemiol. Author manuscript; available in PMC 2008 August 15.
PMCID: PMC2077981"
Clarice R. Weinberg, David L. Shore, David M. Umbach, and Dale P. Sandler
Am J Epidemiol. Author manuscript; available in PMC 2008 August 15.
PMCID: PMC2077981"
Cited by ..
Cited by ..: "Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response
MP Goetz, A Kamal, and MM Ames"
MP Goetz, A Kamal, and MM Ames"
Prospective surveillance of women with a family history of breast cancer
Cited by ..: "Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
E Anderson, J Berg, R Black, N Bradshaw, J Campbell, H Carnaghan, R Cetnarkyj, S Drummond, R Davidson, J Dunlop, A Fordyce, B Gibbons, D Goudie, H Gregory, S Holloway, M Longmuir, L McLeish, V Murday, Z Miedzybrodska, D Nicholson, P Pearson, M Porteous, M Reis, S Slater, K Smith, E Smyth, L Snadden, M Steel, D Stirling, C Watt, C Whyte, and D Young
Br J Cancer. 2008 February 26; 98(4): 840–844. Published online 2008 February 19. doi: 10.1038/sj.bjc.6604155.
PMCID: PMC2259176"
E Anderson, J Berg, R Black, N Bradshaw, J Campbell, H Carnaghan, R Cetnarkyj, S Drummond, R Davidson, J Dunlop, A Fordyce, B Gibbons, D Goudie, H Gregory, S Holloway, M Longmuir, L McLeish, V Murday, Z Miedzybrodska, D Nicholson, P Pearson, M Porteous, M Reis, S Slater, K Smith, E Smyth, L Snadden, M Steel, D Stirling, C Watt, C Whyte, and D Young
Br J Cancer. 2008 February 26; 98(4): 840–844. Published online 2008 February 19. doi: 10.1038/sj.bjc.6604155.
PMCID: PMC2259176"
Age of onset in familial cancer .
Cited by ..: "Age of onset in familial cancer
A. Brandt, J. Lorenzo Bermejo, J. Sundquist, and K. Hemminki
Ann Oncol. 2008 December; 19(12): 2084–2088. Published online 2008 July 24. doi: 10.1093/annonc/mdn527.
PMCID: PMC2733121
Abstract Full Text PDF–72K "
A. Brandt, J. Lorenzo Bermejo, J. Sundquist, and K. Hemminki
Ann Oncol. 2008 December; 19(12): 2084–2088. Published online 2008 July 24. doi: 10.1093/annonc/mdn527.
PMCID: PMC2733121
Abstract Full Text PDF–72K "
streda 2. júna 2010
How to open links in a new window ? at Blogger Templates & Community | Help with blogspot template
How to open links in a new window ? at Blogger Templates & Community Help with blogspot template: "How to open links in a new window ?If you want to open links in a new window you need to do modify your link from
Link to us!
to
Link to us!
Remember that it’s a good ideea to warn your visitors about that by changing the title also in title=”BloggerO - opens in new window”
Another radical way is to add in your template between this line:
<> this line:
< target="”_blank”">
this line: < target="”_blank”">
and all links will open in a new window."
hallelujah - how to write tags in html document ///to make it ignore - use escape sign ampersand & eg < & = ampersand and lowerthan, greaterthan etc.
Link to us!
to
Link to us!
Remember that it’s a good ideea to warn your visitors about that by changing the title also in title=”BloggerO - opens in new window”
Another radical way is to add in your template between this line:
<> this line:
< target="”_blank”">
this line: < target="”_blank”">
and all links will open in a new window."
hallelujah - how to write tags in html document ///to make it ignore - use escape sign ampersand & eg < & = ampersand and lowerthan, greaterthan etc.
research presentation web SCRIPT from CAMBRIDGE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&CrntRpt=DocSum&DB=pubmed&WebEnv=0wdifPSGHVwjqyV9JldVH0eaNUhBzXjZR_NtJ4h9-5c3YthAZF5T5w%406YMSfIIOFtoAABrvUzYAAAAP&cmd=search&db=pubmed&dispmax=20&dispmax1=20&dopt1=DocSum&filters=on&orig_db=pubmed&pubmedFilters=TRUE&query_hl=9&query_key=9&showndispmax=20&term=(Javorsky+M%5BAuthor+Name%5D+OR+Tkac+I%5BAuthor+Name%5D+OR+Stancakova+A%5BAuthor+Name%5D+OR+Laakso+M%5BAuthor+Name%5D)+AND+(2009%5BDP%5D)
ANCHOR A HREF ...
???? PROBLEM - SHOULD OPENNEW WINDOW !!!!!
CF http://www.phpc.cam.ac.uk/MEU/Publications/
2009
http://bloggero.com/23/how-to/how-to-open-links-in-a-new-window
ANCHOR A HREF ...
???? PROBLEM - SHOULD OPENNEW WINDOW !!!!!
CF http://www.phpc.cam.ac.uk/MEU/Publications/
2009
http://bloggero.com/23/how-to/how-to-open-links-in-a-new-window
Prihlásiť na odber:
Príspevky (Atom)